Inhibition of Wnt/β-catenin signaling by SFN occurred downstream of β-catenin degradation, most likely at the level of β-catenin-TCF transcription complex formation, explaining why SFN is still active in mutated colorectal cancer cells. The gene discussed is SFN; the disease is colorectal cancer.